Saleh Stevens

Saleh Stevens is the CEO of Continental Clinical Solutions, a Maryland-based clinical research organization. He began his career with Continental Clinical in the Contract and Regulatory department, completing dynamic assignments with partnerships around the United States. Saleh assumed leadership responsibility in Continental’s mid-Atlantic dedicated research division, based in Baltimore, Maryland. Saleh is passionate about making healthier communities by recruiting suitable patients, finding the best treatments, and delivering medications in areas where they are most needed.

Continental Clinical Solution is a dedicated research facility that boasts a large regional network of investigators, trial sites and patient volunteers for all phases of clinical studies. Saleh focused Continental on clinical studies addressing long-term health issues that plagued local communities. Under Saleh’s leadership, Continental Clinical has grown to become one of the leading clinical research organizations in the country. Saleh is a strong advocate for patient rights and safety, and he continues to lead Continental Clinical in its mission to make a difference in the lives of patients everywhere. Under Saleh’s leadership, Continental has conducted groundbreaking studies on a variety of conditions, including Alzheimer’s disease, diabetes, heart disease and cancer. Saleh’s work has helped to improve the lives of countless patients and their families. Saleh is a true pioneer in the field of clinical research, and his work has made a lasting impact on the health of our community.

Saleh Stevens is a man on a mission. Throughout his career, he has focused on increasing and publicizing diversity in clinical research, including both physician-investigators and patients, as well as utilizing scientific research to educate people in underserved communities about their own power in influencing science. Saleh’s work has been instrumental in bringing much-needed attention to the lack of diversity in clinical research and the need to improve inclusion of underrepresented groups. Saleh has always been passionate about promoting diversity and inclusion in all areas of science and medicine, and he has made it his mission to ensure that everyone has a voice in the scientific community. Saleh believes that everyone deserves the opportunity to participate in clinical research, regardless of their background or identity. By increasing diversity in clinical research, Saleh hopes to obtain a more accurate understanding of the complexities of human health and disease. Additionally, Saleh hopes that by educating people in underserved communities about their power in influencing science, they will be more likely to participate in clinical research and have a positive impact on the future of medicine. Saleh’s dedication to increasing diversity in clinical research is evident in all aspects of his work, and it is clear that he is committed to making a difference in the lives of all people.

In 2014, Saleh Stevens assumed the role of President of Research Operations.  By virtue of a newly formed partnership with a California-based SMO, Continental expanded its research endeavors to include an exhaustive list of therapeutic areas with multiphase hosting capabilities.  With an eye on top line growth in the research division tied to the pipeline market for pharmaceutical development, he turned his focus on fortifying an infrastructure that supports a longterm platform for profitability.  Despite lower than expected performance through the first three quarters of 2014, contracts saw an uptick by year end. Saleh Stevens’ experience and efforts have been integral in growing Continental’s research division.

Saleh Stevens was born and raised in Maryland. Throughout his childhood, Saleh was always aware of the importance of giving back to his community. Saleh’s commitment to serving the community led him to assume the role of CEO at Continental in early 2015. As CEO, Saleh has focused significant efforts on bringing relevant clinical studies and health awareness programs to the local population. Saleh’s ties with community health programs and local leaders have been essential in assuring that Continental serves the community as much as it serves the advancement of science. Saleh’s dedication to the community is evident in all that he does. Saleh is truly a perfect match for Continental, and his leadership has been invaluable in moving the company forward.

When asked about how his role has changed after becoming CEO Saleh says, “I attribute much of this success to my team’s ability to make strategic decisions and be held accountable for their results. I now am in the position to set the direction of the company, make decisions about investments and approve budgets. These are  some of the most important responsibilities of an executive that I now have. I also feel that it is important to be responsive to shareholders. I want to ensure that they are getting a return on their investment, and that the company is continuing to be profitable. I believe that by meeting these responsibilities, my team and I are able to create a successful business.

In Saleh’s work, he has found that only 6 percent of the population participates in clinical research, which means that 94 percent of people are missing out on potentially life-saving treatments. Saleh is committed to closing this gap, and he does so by collaborating with others. He believes that it’s really important to work together if you want to make a lasting impact. Saleh and his team have made significant progress in providing patients with the medications they need, from locating the finest therapies to delivering medicines where they’re most needed. Saleh is proud of their accomplishments and the difference they’ve been able to make in people’s lives. By working together and using their expertise, Saleh and his team are helping to improve access to clinical research for everyone.

Saleh comments on diversity in the workplace and says, “We have seen so many companies make the mistake of not prioritizing diversity and inclusion, and we think it’s time for that to change. We need to do better and be better. We hope that by sharing our own commitment to diversity, we can inspire other businesses to follow suit. Companies that are committed to diversity and inclusion are more successful, innovative, and profitable. I would encourage companies to invest in diversity and inclusion initiatives and create a culture where everyone feels welcome, valued, and respected.”